Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | -.--% | -.--% | -11.11% |
May. 21 | Transcript : StageZero Life Sciences Ltd., Q1 2024 Earnings Call, May 21, 2024 | |
May. 16 | StageZero Life Sciences Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2021 | 5.07M 6.98M | Sales 2022 | 3.8M 5.23M | Capitalization | 4.49M 6.19M |
---|---|---|---|---|---|
Net income 2021 | -7M -9.64M | Net income 2022 | -11M -15.15M | EV / Sales 2021 | 3.99 x |
Net cash position 2021 | 368K 508K | Net Debt 2022 | 1.78M 2.46M | EV / Sales 2022 | 1.65 x |
P/E ratio 2021 |
-2.2
x | P/E ratio 2022 |
-0.39
x | Employees | 40 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 79.62% |
Latest transcript on StageZero Life Sciences Ltd.
3 months | -11.11% | ||
6 months | -11.11% | ||
Current year | -11.11% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 01-12-31 | |
Rebecca Greco
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
FOU | Founder | 71 | 97-12-31 |
Garth MacRae
BRD | Director/Board Member | 90 | 99-12-31 |
Chief Executive Officer | - | 01-12-31 |
1st Jan change | Capi. | |
---|---|---|
-11.11% | 3.59M | |
+45.90% | 57.87B | |
+40.74% | 40.25B | |
-6.74% | 39.94B | |
-5.16% | 28.54B | |
+11.85% | 26.4B | |
-21.02% | 19.33B | |
+29.96% | 12.4B | |
-0.78% | 12.23B | |
+23.68% | 12.2B |
- Stock Market
- Equities
- SZLS Stock